Prescient Therapeutics Ltd Capital Reinvestment Ratio
Prescient Therapeutics Ltd capital reinvestment ratio. Prescient Therapeutics Ltd (PTX) has a Capital Reinvestment Ratio of 0.32x as of June 1993, meaning it reinvests 0% of its operating cash flow (AU$1.74 Million) in capital expenditures (AU$562.00K). Check cash flow reinvestment rate of Prescient Therapeutics Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Prescient Therapeutics Ltd (1991–1993)
Capital reinvestment ratio of Prescient Therapeutics Ltd from 1991 to 1993. This chart tracks Prescient Therapeutics Ltd's Capital Reinvestment Ratio across 2 annual periods. Also explore Prescient Therapeutics Ltd (PTX) equity growth momentum to track the company's year-over-year net asset growth rate.
Prescient Therapeutics Ltd Capital Reinvestment Ratio by Year (1991–1993)
Prescient Therapeutics Ltd capital reinvestment ratio by year from 1991 to 1993. For the full cash flow conversion analysis, see Prescient Therapeutics Ltd (PTX) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 1993 | 0.32x | AU$1.74 Million | AU$562.00K | ▼ -12.3% |
| 1991 | 0.37x | AU$730.00K | AU$269.00K | — |